Arkolith/Insider Trading/OCEL/Form 4/A

Sinnreich Matthew Phillip

President and Acting CEO, DirectorOrganicell Regenerative Medicine, Inc. (OCEL) · full profile →Form 4/A · filed Nov 3, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 31, 2022Other(J)7.0M——0

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001829126-22-018721) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML